Literature DB >> 17005427

[Safety of blood transfusion at the international level. The role of WHO].

N Dhingra1, V Hafner.   

Abstract

Blood safety is an international public health challenge, particularly since the emergence of HIV AIDS. Recognizing the gross disparities between countries in the adequacy of national blood supplies and the risks arising from poorly organized services, particularly in developing countries, the World Health Organization has developed a global strategy for blood safety and availability. Dr N. Dhingra, coordinator, blood transfusion safety, WHO Headquarters, and Dr V. Hafner, focal point for blood safety in the WHO regional office for Europe, present the main features of this strategy: well-organized, nationally coordinated blood transfusion services with quality systems in all areas; the collection of blood only from voluntary non-remunerated blood donors from low-risk populations; the quality-assured testing of all donated blood; the safe and appropriate use of blood and blood products; and global collaboration for blood safety. WHO's programs, some difficulties encountered and outcomes are also described in this article.

Entities:  

Mesh:

Year:  2006        PMID: 17005427     DOI: 10.1016/j.tracli.2006.07.007

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  2 in total

1.  Analysis of donor deferral at three blood centers in Brazil.

Authors:  Thelma T Gonçalez; Ester C Sabino; Karen S Schlumpf; David J Wright; Alfredo Mendrone; Maria Lopes; Silvana Leão; Carolina Miranda; Ligia Capuani; Anna Barbara F Carneiro-Proietti; Fernando Basques; João E Ferreira; Michael Busch; Brian Custer
Journal:  Transfusion       Date:  2012-07-31       Impact factor: 3.157

2.  Prevalence and risk factors for hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in transfused children in Kinshasa.

Authors:  M Katabuka; M E Mafuta; A M Ngoma; P Mutombo Beya; S Yuma; L Aketi; K P Kayembe; J R Gini
Journal:  Indian J Pediatr       Date:  2012-11-24       Impact factor: 1.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.